A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

PHASE4CompletedINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

June 21, 2004

Primary Completion Date

July 26, 2006

Study Completion Date

July 26, 2006

Conditions
Herpes Genitalis
Interventions
DRUG

Valaciclovir

1g once daily

DRUG

Placebo

placebo

Trial Locations (72)

1221

GSK Investigational Site, Buenos Aires

10461

GSK Investigational Site, The Bronx

11203

GSK Investigational Site, Brooklyn

13760

GSK Investigational Site, Endicott

19103

GSK Investigational Site, Philadelphia

27103

GSK Investigational Site, Winston-Salem

27599

GSK Investigational Site, Chapel Hill

30005

GSK Investigational Site, Alpharetta

30033

GSK Investigational Site, Decatur

30310

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

32901

GSK Investigational Site, Melbourne

33134

GSK Investigational Site, Coral Gables

33407

GSK Investigational Site, West Palm Beach

33461

GSK Investigational Site, Palm Springs

33759

GSK Investigational Site, Clearwater

34285

GSK Investigational Site, Venice

35294

GSK Investigational Site, Birmingham

38104

GSK Investigational Site, Memphis

38120

GSK Investigational Site, Memphis

46601

GSK Investigational Site, South Bend

49024

GSK Investigational Site, Portage

53186

GSK Investigational Site, Waukesha

54601

GSK Investigational Site, La Crosse

60612

GSK Investigational Site, Chicago

62702

GSK Investigational Site, Springfield

70114

GSK Investigational Site, New Orleans

73112

GSK Investigational Site, Oklahoma City

74104

GSK Investigational Site, Tulsa

76104

GSK Investigational Site, Fort Worth

77058

GSK Investigational Site, Houston

78205

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

78626

GSK Investigational Site, Georgetown

78746

GSK Investigational Site, Austin

85016

GSK Investigational Site, Phoenix

85710

GSK Investigational Site, Tucson

89128

GSK Investigational Site, Las Vegas

90048

GSK Investigational Site, Los Angeles

90211

GSK Investigational Site, Beverly Hills

92123

GSK Investigational Site, San Diego

92128

GSK Investigational Site, San Diego

92704

GSK Investigational Site, Santa Ana

92805

GSK Investigational Site, Anaheim

94102

GSK Investigational Site, San Francisco

95616

GSK Investigational Site, Davis

95628

GSK Investigational Site, Fair Oaks

95816

GSK Investigational Site, Sacramento

95825

GSK Investigational Site, Sacramento

97210

GSK Investigational Site, Portland

99204

GSK Investigational Site, Spokane

7580206

GSK Investigational Site, Santiago

8380456

GSK Investigational Site, Santiago

06012

GSK Investigational Site, Hartford

06052

GSK Investigational Site, New Britain

46202 - 5124

GSK Investigational Site, Indianapolis

02114

GSK Investigational Site, Boston

02780

GSK Investigational Site, Taunton

11794-8091

GSK Investigational Site, Stony Brook

02914

GSK Investigational Site, East Providence

53209-0996

GSK Investigational Site, Milwaukee

C1114AAP

GSK Investigational Site, Buenos Aires

90035-903

GSK Investigational Site, Porto Alegre

90470-340

GSK Investigational Site, Porto Alegre

20 551-030

GSK Investigational Site, Rio de Janeiro

T6G 2C8

GSK Investigational Site, Edmonton

R3C 0N2

GSK Investigational Site, Winnipeg

K1S 0G8

GSK Investigational Site, Ottawa

M5V 2T3

GSK Investigational Site, Toronto

H2L 4P9

GSK Investigational Site, Montreal

G1V 4G2

GSK Investigational Site, Sainte-Foy

G1S 2L6

GSK Investigational Site, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY